Status:
COMPLETED
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
Lead Sponsor:
University of Brasilia
Conditions:
Localized Cutaneous Leishmaniasis
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
This study was designed to evaluate the effect of low doses of pentavalent antimony (meglumine antimoniate) to treat cutaneous leishmaniasis ulcers in patients older than 65 years. The hypothesis is t...
Eligibility Criteria
Inclusion
- Age \> 65 years
- Permanent residence in the endemic area
- Availability of a caregiver for dependent patients
Exclusion
- Mucosal disease caused by leishmaniasis
- Disseminated cutaneous disease
- Severe cardiac, renal or hepatic disorders
- Active cancer
- Active tuberculosis
- Leprosy
- HIV positive
- Total bilirubin \> 1.5mg/dL
- Urea and creatinin \> 1.5 times the upper normal level
- Alkaline phosphatase and aminotransferases \> 2.5 times the upper normal level
- Lipase and amylase \> 1.5 the upper normal level
- Hemoglobin \< 5 g/dL of
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00818818
Start Date
August 1 2008
End Date
April 1 2010
Last Update
October 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Center Unit of Corte de Pedra
Corte de Pedra, Presidente Tancredo Neves, Bahia State, Brazil, 45416 - 000